Garadacimab (Anti-F12 / Factor XII)

Ask supplier a question | View on supplier's website

Garadacimab (Anti-F12 / Factor XII) is a first-in-class, fully human IgG4 monoclonal antibody targeting activated factor XII (FXIIa). Garadacimab has the potential for hereditary angioedema research. MW: 145.5 KD.

Supplier	Selleck Chemicals
Product #	A2503
Sku #	A2503-1mg*25
Pricing	1mg*25, $2970.00

Feedback